Application of comprehensive unit-based safety program model to improve chemotherapy-induced nausea and vomiting in patients with ovarian cancer: a retrospective study

[1]  I. Endo,et al.  Risk factors of chemotherapy-induced nausea and vomiting in patients with metastatic colorectal cancer: a prospective cohort study (YCOG1301) , 2020, International Journal of Colorectal Disease.

[2]  T. Leblanc,et al.  What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  L. Hefler,et al.  Implementation of a comprehensive unit-based safety program to reduce surgical site infections in cesarean delivery. , 2020, American journal of infection control.

[4]  Jessica M. Ameling,et al.  Multistate programme to reduce catheter-associated infections in intensive care units with elevated infection rates , 2020, BMJ Quality & Safety.

[5]  J. Sehouli,et al.  Prognostic role of chemotherapy-induced nausea and vomiting in recurrent ovarian cancer patients: results of an individual participant data meta-analysis in 1213 , 2019, Supportive Care in Cancer.

[6]  M. Chamari,et al.  Randomized Study of the Effect of Dietary Counseling During Adjuvant Chemotherapy on Chemotherapy Induced Nausea and Vomiting, and Quality of Life in Patients With Breast Cancer , 2018, Nutrition and cancer.

[7]  Wen-Pei Chang,et al.  Does the Oral Administration of Ginger Reduce Chemotherapy-Induced Nausea and Vomiting?: A Meta-analysis of 10 Randomized Controlled Trials. , 2018, Cancer nursing.

[8]  K. Jerzak,et al.  ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients , 2018, Supportive Care in Cancer.

[9]  Y. Arabi,et al.  Implementing the comprehensive unit-based safety program model to improve the management of mechanically ventilated patients in Saudi Arabia , 2018, American Journal of Infection Control.

[10]  M. Aapro.  CINV: still troubling patients after all these years , 2018, Supportive Care in Cancer.

[11]  A. Yeung,et al.  A Review Study on the Beneficial Effects of Baduanjin. , 2017, Journal of alternative and complementary medicine.

[12]  A. Molassiotis,et al.  The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  E. Bruera,et al.  2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  J. Marsteller,et al.  Influence of the Comprehensive Unit–based Safety Program in ICUs , 2016, American journal of medical quality : the official journal of the American College of Medical Quality.

[15]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[16]  C. Clements,et al.  Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. , 2007, Journal of pain and symptom management.

[17]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[18]  J. Pearson,et al.  Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index—Emesis (FLIE) with 5-day recall , 2003, Supportive Care in Cancer.

[19]  Neha J. Darrah,et al.  A Case of "Total Nausea:" An Interprofessional Approach to the Management of Chemotherapy-Induced Nausea/Vomiting Complicated by Anxiety and Existential Distress. , 2018, Journal of pain and symptom management.

[20]  A. Vallerand,et al.  Chemotherapy-Induced Nausea and Vomiting Mitigation With Music Interventions
. , 2018, Oncology nursing forum.

[21]  N. Ngamphaiboon,et al.  A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy , 2017, Medical Oncology.